NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) | PAR 19 258

Opportunity Information: Apply for PAR 19 258

The NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed), funding opportunity number PAR-19-258, is a National Institutes of Health discretionary grant program designed to strengthen the research education pipeline in areas aligned with NIH and National Institute on Drug Abuse (NIDA) priorities. It uses the NIH R25 mechanism, which is specifically meant to support structured research education activities rather than standard research projects or routine clinical training. The central purpose of this opportunity is to build and improve the workforce needed to meet the United States' biomedical, behavioral, and clinical research needs, with this particular announcement focusing on substance use and substance use disorder (SUD) research.

A key feature of the program is its emphasis on clinically oriented participants. The intended audience includes people already in clinically focused careers and individuals preparing for careers as clinicians or health service providers, clinical researchers, or ideally professionals who combine clinical practice with research responsibilities. In practical terms, the grant supports educational experiences that deepen participants knowledge and skills in substance use and SUD research, helping clinicians and clinician-researchers better understand the science behind prevention, diagnosis, treatment, recovery, and the broader public health impact of substance use. While the grant is meant to enhance research-related competencies, it explicitly cannot be used to pay for non-research-related clinical training, meaning it is not intended to fund typical clinical rotations, licensure requirements, or purely service-oriented training that is not directly tied to research education goals.

This opportunity is categorized under education and health and is associated with CFDA number 93.279. The funding instrument is a grant, and the listed award ceiling is $350,000. The sponsoring agency is the National Institutes of Health. Based on the information provided, the original closing date was August 11, 2021, and the opportunity record indicates a creation date of April 23, 2019.

Eligibility is broad and includes many types of organizations that can carry out research education programming. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; tribal organizations that are not federally recognized governments; and a range of nonprofit and for-profit entities, including small businesses. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This breadth reflects an intention to reach diverse training environments and expand research education capacity across different communities and institutional settings.

Overall, PAR-19-258 is best understood as a workforce development and research education grant focused on improving the knowledge base and research readiness of clinicians and clinical researchers working in or entering the substance use and SUD field. It is aimed at strengthening research education offerings that complement existing career pathways, expanding the number of professionals who can contribute to evidence-based advances in substance use science, and doing so through formal educational activities rather than clinical service training or clinical trials.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
• This funding opportunity was created on 2019-04-23.
• Applicants must submit their applications by 2021-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $350,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 19 258

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: